| |
|
|
TOTAL |
Padova
group |
Udine
group |
Cancer site/type
(ICD-10) |
Obs.
Tot. (PD/UD) |
IR
*100.000 |
SIR |
95% CI |
SIR (95% CI) |
SIR (95% CI) |
|
| |
|
|
|
|
|
|
|
| Head and neck (C00-14 and 30, 32) |
7(4/3) |
231.4 |
4.6 |
1.3-11.9 |
4.4 (0.5-16.1) |
4.8 (0.6-17.5) |
|
| Esophagus (C15) |
5 (3/2) |
171.8 |
18.7 |
3.9-54.7 |
12.1 (0.3-67.6) |
25.7 (3.1-92.9) |
|
| Stomach (C16) |
3(2/1) |
171.3 |
4.3 |
0.9-12.6 |
5.6 (0.7-20.4) |
2.9 (0.1-16.4) |
|
| Colon (C18) |
2(2/0) |
114.9 |
2.5 |
0.3-9.2 |
5.2 (0.6-18.8) |
NC |
|
| Lung (C34) |
4 (2/2) |
114.2 |
0.9 |
0.1-3.2 |
0.9 (0.0-4.8) |
0.9 (0.0-5.2) |
|
| Melanoma of skin (C43) |
2 (1/1) |
114.4 |
10.1 |
1.2-36.3 |
9.5 (0.2-53.2) |
10.6 (0.3-59.2) |
|
| Kaposi’s sarcoma (C46) |
6 (6/0) |
291.5 |
211.6 |
68.7-493.8 |
370.2 (120.2-863.9) |
NC |
|
| Breast, female (C50) |
1(0/1) |
193.3 |
1.2 |
0.0-6.7 |
NC |
2.1 (0.1-12.0) |
|
| Cervix uteri (C53) |
2 (2/0) |
192.8 |
12.8 |
0.3-71.4 |
28.1 (0.7-156.5) |
NC |
|
| Non Hodgkin’s Lymphoma (C82-85,C96) |
8 (3/5) |
286.7 |
13.7 |
4.5-32.0 |
10.7 (1.3-38.7) |
16.9 (3.5-49.3) |
|
| |
|
|
|
|
|
|
|
| All cancers but skin |
40 (25/15) |
1822.1 |
3.0 |
2.0-4.3 |
4.0 (2.4-6.2) |
2.1 (1.1-3.8) |
|
|
